Wide Ranks

DRTS

Alpha Tau Medical Ltd.

2.80

Top Statistics
Market Cap 196 M Forward PE -5.89 Revenue Growth 0.00 %
Current Ratio 11.66 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.90 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 71 M Total Cash Per Share 1.02 Total Debt 12 M
Total Debt To Equity 16.97 Current Ratio 11.66 Book Value Per Share 1.21
All Measures
Short Ratio 301.00 % Message Board Id finmb_531816986 Shares Short Prior Month 43565
Return On Equity -0.3317 City Jerusalem Uuid d9da6b97-0879-3a14-a715-9f57f7b77249
Previous Close 2.85 First Trade Date Epoch Utc 1 B Book Value 1.21
Beta 0.7710 Total Debt 12 M Volume 119825
Price To Book 2.31 Fifty Two Week Low 1.75 Total Cash Per Share 1.02
Shares Short Previous Month Date 1 B Target Median Price 8.50 Max Age 86400
Recommendation Mean 1.50 Sand P52 Week Change 0.3133 Target Mean Price 8.75
Net Income To Common -27627000 Short Percent Of Float 0.0013 Implied Shares Outstanding 70 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 56620
Average Volume10days 56620 Total Cash 71 M Next Fiscal Year End 1 B
Held Percent Insiders 0.2556 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 2.85 Target Low Price 5.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.30 Open 2.94
Free Cashflow -19490500 Dividend Yield 0.00 % Return On Assets -0.2192
Time Zone Short Name EST Trailing Eps -0.4300 Day Low 2.71
Address1 Kiryat Hamada Street 5 Shares Outstanding 70 M Price Hint 4
Target High Price 13.00 Website https://www.alphatau.com 52 Week Change -0.1463
Average Volume 28657 Forward Eps -0.4900 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 1100.20 % Is_sp_500 False
Regular Market Day High 2.98 Profit Margins 0.00 % Debt To Equity 16.97
Fifty Two Week High 3.40 Day High 2.98 Shares Short 67056
Regular Market Open 2.94 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0010 Operating Cashflow -20839000
Currency USD Time Zone Full Name America/New_York Market Cap 196 M
Is_nasdaq_100 False Zip 9777605 Quote Type EQUITY
Industry Biotechnology Long Name Alpha Tau Medical Ltd. Regular Market Day Low 2.71
Held Percent Institutions 0.0195 Current Price 2.80 Enterprise To Ebitda -2.90
Financial Currency USD Current Ratio 11.66 Industry Disp Biotechnology
Number Of Analyst Opinions 4 Country Israel Float Shares 51 M
Two Hundred Day Average 2.46 Enterprise Value 102 M Forward PE -5.89
Regular Market Volume 119825 Ebitda -35224000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Alpha Tau Medical Ltd.

, a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States.

The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.

Alpha Tau Medical Ltd.

was incorporated in 2015 and is headquartered in Jerusalem, Israel.